Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19139430 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: Hydralazine/Magnesium;   Drug: Placebo;   Drug: Carboplatin;   Drug: Paclitaxel

Study has passed its completion date and status has not been verified in more than two years.